• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX25 HOLLOW FIBER OXYGENATOR AF OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX25 HOLLOW FIBER OXYGENATOR AF OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX*FX25E
Device Problems Device Damaged Prior to Use (2284); Out-Of-Box Failure (2311)
Patient Problem No Patient Involvement (2645)
Event Date 03/09/2017
Event Type  malfunction  
Manufacturer Narrative
The actual device has been returned to the manufacturing facility for evaluation. The investigation is currently ongoing. A follow up report will be submitted once the investigation is complete. For this reason, (b)(4) has been referenced in the conclusions section of evaluation codes. A review of the device history records and product release decision control sheet of the involved product code/lot # combination was conducted with no relevant findings. A search of the complaint file found no other report with the involved product code/lot# combination. (b)(4). All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Event Description
The user facility reported the temperature port was found broken when removed from box. Follow up communication with the user facility reported the following information: there was no patient involvement.
 
Manufacturer Narrative
This report is being submitted as follow up number 1 to provide the returned device evaluation results. Visual inspection found the thermistor probe on the outlet port had been broken off. Magnifying inspection of the thermistor probe confirmed that it had not been deformed. The actual sample was filled with saline solution. With the blood outlet port clamped pressure was applied to the actual sample from the blood pathway for 6 hours. No leak was confirmed. Visual inspections under magnification and electron microscope of the fracture cross section confirmed there was no embedded particle which would deteriorate the product strength. On the surface, some parts were in the smooth state and other parts were in the rough state. On the smooth surface, the presence of some streaks was found. Simulation testing was conducted. A sample pulled from the current production run was subjected to an instantaneous shock force on the thermistor probe. The probe became fractured. Subsequent electron microscopic inspection of the fracture cross-section found that the surface on the side the shock force had been applied was in the smooth state and the surface on the opposite side was in the rough state. On the smooth surface some streaks going toward the rough surface were found to have been generated. On the surface of the thermistor probe, there was not any deformation. The damage to the actual sample was duplicated. There is no evidence that this event was related to a device defect or malfunction. While the exact cause of the reported event cannot be definitively determined based on the available information, it is likely the actual sample was exposed to some shock force which exceeded the product's strength limit on the thermistor probe resulting in the reported event. The device labeling does address the potential for such an event in the instruction for use (ifu) with the statement such as the following: "do not use if the package or device is damaged (e. G. Cracked) or any of the port caps are off. " all available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameCAPIOX FX25 HOLLOW FIBER OXYGENATOR AF
Type of DeviceOXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA 418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA 418
Manufacturer Contact
jennifer suh
reg. no. 2243441
2101 cottontail ln.
somerset, NJ 08873
8002837866
MDR Report Key6465211
MDR Text Key72127435
Report Number9681834-2017-00066
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation
Type of Report Initial,Followup
Report Date 04/06/2017
1 Device was Involved in the Event
0 Patients were Involved in the Event:
Date FDA Received04/06/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator
Device Expiration Date10/31/2019
Device Catalogue NumberCX*FX25E
Device Lot Number161111
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/03/2017
Is the Reporter a Health Professional? No
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received04/03/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/11/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

-
-